Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Analysis of cohort 2 for B-UP should be next week. What else George?
Leo is listening to everything. It's too early for a big buyout. He wants to maximize for all shareholders. I have no idea what number he has in mind. But, if someone came along today, next month or next year with the right number he would be all ears
That's where I remembered the 400,000 figure from. People in US suffering from OM
I think one PR said 400,000
George. You are a true believer as I am but I think you're a bit over the top
There are very few antibiotics in development. The FDA requires huge numbers of subjects to be tested to satisfy their needs. Very expensive and time consuming. BP wants proven results. They will pay up for an approved drug.
I heard a biotech analyst today say that BP has no antibiotic drugs in the pipeline. Something about difficulty of getting approved. Why is that? Karen? BK?
A buyer or partner for B-UP will want the whole franchise not just UP. This will make the bidding a bit complicated.
Same old. Why look back. Waste of energy. Management is loaded with stock and options. They're not buying anymore. Leo has managed the cash very well. The science will win out. Not too long
Sullivan wrote the response
Sullivan wrote the response
Was this hit job to create one more flush for them to cover their shorts?
Bght more at 1.03 & 1.06
B-UP started in July. We got interim in October. 3 mos. now we should get another 3 mos later
That's absurd. Leo is budgeting properly no need to dilute us to oblivion
B-UP interim results should be out soon
Experience tells me we should expect nothing from the conference. They are looking for exposure.
We had B-UP interim in October. 3 mos in. Would expect another interim in January
Leo has said he doesn't want to partner B until phase 3 is complete in order to maximize value of B. He knows he can partner B at any time but not maximize value
So that's 10+9+30=49B. Fully diluted $270 per share. Not bad
6-11%. The point it's still a lot of stock being thrown on the market....
I believe Leo has done an outstanding job managing the money and dilution.
I own a ton. Absolutely a bull.
So it's 23 to 25. Close enuf for government work
The point being. Aspire is a significant source of stock. They don't want to go over the 5% reporting level. We seem to have found a level where there are significant buyers for the stock. We need hard results and a real partnership
They don't raise on a daily basis but I'm using approx averages
Aspire is selling 30K shs per day on average.
Someone is at 1.15 buying it all
Someone bought that big volume without moving the stock very much.
Just got filled on another 10K @ 1.15
Check will be much bigger with phase 3 results
January should see intermediate B-UP results and hopefully Judge will award us some money
Leo must bring results to a buyer. Nothing less. Then we fund everything else by ourselves. He has enough funding available to get there. There will be a bit more dilution but that's the price we pay
That's me
They won't nor should they
George, I love an optimist. But man, I think your numbers are just too high. No matter how good a drug may be it takes years for it to hit your numbers
I believe Leo and Menon have options on approx 20 million shares each in addition to what shares they own outright.
Absolutely no evidence that Leo is selling
Blue Horseshoe loves Cellceutix
Bunny just made that up. Ridiculous
that was tongue in cheek